RETRACTION: Tumorigenic Study on Hepatocytes Coexpressing SV40 With Ras.

IF 3.2 2区 医学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
{"title":"RETRACTION: Tumorigenic Study on Hepatocytes Coexpressing SV40 With Ras.","authors":"","doi":"10.1002/mc.70046","DOIUrl":null,"url":null,"abstract":"<p><strong>Retraction: </strong>B. Sun, M. Chen, C. Hawks, P. J. Hornsby, and X. Wang, \"Tumorigenic Study on Hepatocytes Coexpressing SV40 With Ras,\" Molecular Carcinogenesis 45 no. 4 (2006): 213-219, https://doi.org/10.1002/mc.20137. The above article, published online on 19 September 2005 in Wiley Online Library (wileyonlinelibrary.com) has been retracted by agreement between the authors; the journal Editor-in-Chief; and Wiley Periodicals LLC. The authors identified a significant discrepancy between the legend of Figure 3 and its corresponding description in the Results section. Specifically, the figure legend cites the use of \"HCA2 cells,\" whereas the Results section explicitly describes experiments conducted with \"human hepatocyte lines HL-7702 and HL-7703.\" To resolve this discrepancy and validate the critical findings, the authors attempted to replicate the experiments using the original HL-7702/HL-7703 cell systems. However, two irremediable constraints precluded verification: First, the extended time interval of nearly two decades since publication had rendered the original biological materials nonviable due to natural degradation. Second, essential plasmid constructs required for experimental replication were permanently lost during multiple laboratory relocations over this period. Consequently, the core conclusions remain experimentally unverifiable. Given that the figure-result contradiction cannot be resolved through standard correction measures and considering the irretrievable inability to replicate the study's key outcomes, we conclude that the continued availability of this paper irreparably compromises the validity of the study's conclusions and risks perpetuating misleading information. Therefore, the article must be retracted.</p>","PeriodicalId":19003,"journal":{"name":"Molecular Carcinogenesis","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Carcinogenesis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/mc.70046","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Retraction: B. Sun, M. Chen, C. Hawks, P. J. Hornsby, and X. Wang, "Tumorigenic Study on Hepatocytes Coexpressing SV40 With Ras," Molecular Carcinogenesis 45 no. 4 (2006): 213-219, https://doi.org/10.1002/mc.20137. The above article, published online on 19 September 2005 in Wiley Online Library (wileyonlinelibrary.com) has been retracted by agreement between the authors; the journal Editor-in-Chief; and Wiley Periodicals LLC. The authors identified a significant discrepancy between the legend of Figure 3 and its corresponding description in the Results section. Specifically, the figure legend cites the use of "HCA2 cells," whereas the Results section explicitly describes experiments conducted with "human hepatocyte lines HL-7702 and HL-7703." To resolve this discrepancy and validate the critical findings, the authors attempted to replicate the experiments using the original HL-7702/HL-7703 cell systems. However, two irremediable constraints precluded verification: First, the extended time interval of nearly two decades since publication had rendered the original biological materials nonviable due to natural degradation. Second, essential plasmid constructs required for experimental replication were permanently lost during multiple laboratory relocations over this period. Consequently, the core conclusions remain experimentally unverifiable. Given that the figure-result contradiction cannot be resolved through standard correction measures and considering the irretrievable inability to replicate the study's key outcomes, we conclude that the continued availability of this paper irreparably compromises the validity of the study's conclusions and risks perpetuating misleading information. Therefore, the article must be retracted.

撤回:SV40与Ras共表达肝细胞的致瘤性研究。
引用本文:王晓霞,陈敏,王晓霞,王晓霞,“肝细胞共表达SV40和Ras的研究”,《中华肿瘤杂志》第45期。4 (2006): 213-219, https://doi.org/10.1002/mc.20137。上述文章于2005年9月19日在Wiley在线图书馆(wileyonlinelibrary.com)上发表,经作者同意撤回;期刊总编辑;和Wiley期刊有限责任公司。作者发现图3的图例与结果部分中相应的描述之间存在显著差异。具体来说,图例引用了“HCA2细胞”的使用,而结果部分明确描述了使用“人类肝细胞系HL-7702和HL-7703”进行的实验。为了解决这一差异并验证关键发现,作者试图使用原始的HL-7702/HL-7703细胞系统重复实验。然而,有两个无法弥补的限制阻碍了核查:第一,自发表以来近二十年的时间间隔使原始生物材料由于自然降解而无法生存。其次,在此期间的多次实验室搬迁中,实验复制所需的基本质粒结构永久丢失。因此,核心结论在实验上仍然无法验证。考虑到数据与结果的矛盾无法通过标准的纠正措施来解决,并考虑到不可挽回的无法复制研究的关键结果,我们得出结论,本文的持续可用性不可挽回地损害了研究结论的有效性,并有可能使误导性信息永久化。因此,这篇文章必须撤回。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Carcinogenesis
Molecular Carcinogenesis 医学-生化与分子生物学
CiteScore
7.30
自引率
2.20%
发文量
112
审稿时长
2 months
期刊介绍: Molecular Carcinogenesis publishes articles describing discoveries in basic and clinical science of the mechanisms involved in chemical-, environmental-, physical (e.g., radiation, trauma)-, infection and inflammation-associated cancer development, basic mechanisms of cancer prevention and therapy, the function of oncogenes and tumors suppressors, and the role of biomarkers for cancer risk prediction, molecular diagnosis and prognosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信